相关实验视频

Updated: Jul 13, 2025

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

帕拉米克索病毒:病原体,疫苗,抗病毒药物和疫情准备的原型

W Paul Duprex^1,2, Rebecca Ellis Dutch³

¹Center for Vaccine Research.

The Journal of infectious diseases

|October 18, 2023

概括

帕拉米克索病毒,包括麻疹和尼帕病毒,由于传染率和死亡率高,构成流行病威胁. 本综述确定了研究缺陷,并提出了研究这种病毒家族的原型病原体.

科学领域:

病毒学病毒学
传染性疾病传染性疾病
公共卫生公共卫生

背景情况:

帕拉米克索病毒家族包括重要的人类病原体,如麻疹病毒和尼帕病毒,以及鲜为人知的新兴病毒.
帕拉米克索病毒表现出高人对人传播率和高病例死亡率,这表明有很大的流行病潜力.

研究的目的:

审查导致系统性和呼吸道感染的Paramyxoviridae的一般生命周期,分类学和病变发生.
通过专家咨询和文献审查,确定了解这种病毒家族的关键研究缺口.
为研究Paramyxoviridae提出和评估潜在的原型病原体.

主要方法:

关于Paramyxoviridae生命周期,分类学和病变发生的文献综述.
与主题专家进行商,以确定主要研究领域.
评估潜在的原型病原体,包括它们的优缺点.

主要成果:

详细描述Paramyxoviridae感染的情况,包括全身和呼吸道感染.
在帕拉米克索病毒研究中识别关键知识缺口.
对候选原型病原体进行评估,用于未来的研究.

结论:

帕拉米克索病毒由于其多样化的致病潜力,使其成为严重的公共卫生问题.
解决发现的研究缺口对于对已知和未知的帕拉米克索病毒做好准备至关重要.
拟议的原型病原体为推进对Paramyxoviridae家族的研究提供了有价值的模型.

关键词:

全球疫情防控准备工作这种病毒是paramyxovirus.原型病原体的原型病原体动物性疾病是动物性疾病.

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Expression and Purification of Virus-like Particles for Vaccination

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

相关概念视频

Vaccinations

Vaccinations

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Viruses with RNA Genomes

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...

Viral Recombination

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

Viral Structure

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.